US20200222090A1 - Intermedullary devices for generating and applying compression within a body - Google Patents
Intermedullary devices for generating and applying compression within a body Download PDFInfo
- Publication number
- US20200222090A1 US20200222090A1 US16/836,124 US202016836124A US2020222090A1 US 20200222090 A1 US20200222090 A1 US 20200222090A1 US 202016836124 A US202016836124 A US 202016836124A US 2020222090 A1 US2020222090 A1 US 2020222090A1
- Authority
- US
- United States
- Prior art keywords
- barb
- intramedullary
- bone
- engaging feature
- constrained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000006835 compression Effects 0.000 title description 21
- 238000007906 compression Methods 0.000 title description 21
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 118
- 239000012634 fragment Substances 0.000 claims abstract description 63
- 229910001000 nickel titanium Inorganic materials 0.000 claims abstract description 11
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000004927 fusion Effects 0.000 description 150
- 239000000837 restrainer Substances 0.000 description 30
- 210000001872 metatarsal bone Anatomy 0.000 description 28
- 239000012781 shape memory material Substances 0.000 description 14
- 229910001566 austenite Inorganic materials 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 229910000734 martensite Inorganic materials 0.000 description 8
- 208000010392 Bone Fractures Diseases 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 206010061159 Foot deformity Diseases 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 5
- 208000000013 Hammer Toe Syndrome Diseases 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000003371 toe Anatomy 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 4
- 0 C(C1)C11CC*CC1 Chemical compound C(C1)C11CC*CC1 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229920002530 polyetherether ketone Polymers 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 208000006670 Multiple fractures Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 210000000455 fourth toe Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 210000000453 second toe Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 2
- 210000000431 third toe Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- AWYMFBJJKFTCFO-UHFFFAOYSA-N C(C1)C2C1CCC2 Chemical compound C(C1)C2C1CCC2 AWYMFBJJKFTCFO-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/72—Intramedullary pins, nails or other devices
- A61B17/7233—Intramedullary pins, nails or other devices with special means of locking the nail to the bone
- A61B17/7258—Intramedullary pins, nails or other devices with special means of locking the nail to the bone with laterally expanding parts, e.g. for gripping the bone
- A61B17/7266—Intramedullary pins, nails or other devices with special means of locking the nail to the bone with laterally expanding parts, e.g. for gripping the bone with fingers moving radially outwardly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/72—Intramedullary pins, nails or other devices
- A61B17/7291—Intramedullary pins, nails or other devices for small bones, e.g. in the foot, ankle, hand or wrist
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00946—Material properties malleable
Definitions
- the present invention relates to devices and methods for generating, applying, and maintaining compression to a site in a human or animal body in order to effect healing of diseased or damaged tissue.
- the invention finds particular utility in the field of orthopedics and specifically for generating and maintaining compression between bone fragments that are to be fused. While the invention has application throughout the body, its utility will be illustrated herein in the context of the repair of injured bone tissue, such as the proximal and distal interphalangeal joint of the second, third, or fourth toe and/or fingers. Additionally, the invention has application to aid in the fusion of broken ribs, etc.
- Intramedullary devices are often used for fractures of the long bones; however, they are also frequently used in the phalanges and specifically for the treatment of “hammer toe”, which is a deformity of the proximal interphalangeal joint of the second, third, or fourth toe causing the toe to be permanently bent.
- Typical intramedullary devices used in the phalanges have opposing ends that are adapted to grip against the wall of the intramedullary canal.
- intramedullary devices are typically made of titanium alloys, stainless steel alloys, Nitinol and other materials, e.g., PEEK.
- the titanium alloy devices and stainless steel alloy devices often have barbs or threaded regions at their opposing ends to grip the wall of the intramedullary canal.
- the Nitinol devices typically have a pair of radially extending “legs” at their opposing ends that expand outward when warmed to body temperature, with the pair of legs at each end being disposed in a common plane.
- the present invention comprises the provision and use of novel intramedullary devices that are better able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs.
- apparatus for securing a first bone fragment to a second bone fragment comprising: a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the first end of the shaft may be advanced into a hole in the first bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft but is prevented from being withdrawn from the hole in the first bone fragment when the at least one barb is in its unbiased condition; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares
- a method for securing a first bone fragment to a second bone fragment comprising: providing a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the first end of the shaft may be advanced into a hole in the first bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft but is prevented from being withdrawn from the hole in the first bone fragment when the at least one barb is in its unbiased condition; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition
- apparatus for securing a first bone fragment to a second bone fragment comprising: a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the first end of the shaft may be advanced into a hole in the first bone fragment but prevents the first end of the shaft from being withdrawn from the hole in the first bone fragment; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a
- a method for securing a first bone fragment to a second bone fragment comprising: providing a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the first end of the shaft may be advanced into a hole in the first bone fragment but prevents the first end of the shaft from being withdrawn from the hole in the first bone fragment; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained
- FIGS. 1-4 are schematic views showing an intramedullary fusion device formed in accordance with the present invention.
- FIG. 4A is a schematic view showing removable retaining tabs which may be used to hold the first and second barbed end regions of the intramedullary fusion device of FIGS. 1-4 in their radially constrained condition;
- FIGS. 5-15 are schematic views showing the novel intramedullary fusion device of FIGS. 1-4 being used to treat a hammer toe condition;
- FIG. 15A is a schematic view showing another intramedullary fusion device formed in accordance with the present invention.
- FIG. 15B is a schematic view showing another intramedullary fusion device formed in accordance with the present invention.
- FIGS. 16-18 are schematic views showing another intramedullary fusion device formed in accordance with the present invention.
- FIGS. 19-25 are schematic views showing an intramedullary fusion system formed in accordance with the present invention.
- FIGS. 26-36 are schematic views showing the novel intramedullary fusion system of FIGS. 19-25 being used to treat a hammer toe condition.
- FIG. 37 is a schematic view showing another intramedullary fusion device formed in accordance with the present invention and which may be used with the intramedullary fusion system shown in FIGS. 19-25 .
- the present invention comprises the provision and use of novel intramedullary devices that are better able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs.
- an intermedullary fusion device 5 manufactured from a shape memory material (e.g., a material capable of exhibiting superelasticity and/or a temperature-induced shape change).
- the shape memory material may be a metal alloy (e.g., Nitinol) or a polymer (e.g., appropriately processed PEEK).
- Intramedullary fusion device 5 comprises a first barbed end region 10 , a second barbed end region 15 , and a central bridge region 20 connecting first barbed end region 10 to second barbed end region 15 .
- Intramedullary fusion device 5 is preferably cannulated so as to allow the intramedullary fusion device to be installed over a k-wire if desired, while also allowing a k-wire to be passed through the intramedullary fusion device following implantation if the surgeon desires to fuse a distal or proximal joint.
- the first and second barbed regions flare outward in multiple planes, preferably engaging the surrounding bone about the full circumference of the intramedullary fusion device, thereby providing excellent torsional stability to the fusion site.
- First barbed end region 10 comprises a plurality of barbs 25 which, in their unbiased condition, flare outward from the longitudinal axis of intramedullary fusion device 5 in the manner shown in FIG. 1 .
- the flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable first barbed end region 10 to better engage the “hourglass-shaped” intramedullary canal. The better that first barbed end region 10 engages the intramedullary canal, the more even the pressure distribution will be.
- barbs 25 can be strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 and constrained in that position (e.g., via a removable retaining tab 30 , FIGS.
- Barbs 25 can be constrained in a state where they partially occupy the cannulation of intramedullary fusion device 5 (i.e., where barbs 25 are strained to a point past parallel to the longitudinal axis of intramedullary fusion device 5 ), thereby further reducing the cross-sectional area of first barbed end region 10 . This is beneficial for accessing the intramedullary canal through a small drilled hole.
- FIG. 1 illustrates a device with four barbs 25 on first barbed end region 10
- first barbed end region 10 can be made with more or fewer barbs.
- barbs 25 are allowed to flare outward again, whereby to grip the side wall of the drilled hole and intramedullary canal receiving first barbed end region 10 , whereby to lock first barbed end region 10 to a bone fragment via an expansive force on the intramedullary canal, as will also hereinafter be discussed.
- barbs 25 of first barbed end region 10 are separated from one another by relatively small longitudinal gaps when barbs 25 are strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 , such that barbs 25 collectively provide a substantially full circumferential structure for first barbed end region 10 (i.e., when barbs 25 are strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 , barbs 25 collectively provide a substantially continuous extension of central bridge region 20 of intramedullary fusion device 5 ). See FIGS. 3 and 4 .
- Second barbed end region 15 comprises a plurality of barbs 35 which, in their unbiased condition, flare outward from the longitudinal axis of intramedullary fusion device 5 in the manner shown in FIG. 1 .
- the flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable second barbed end region 15 to better engage the “hourglass-shaped” intramedullary canal.
- the better that second barbed end region 15 engages the intramedullary canal the more even the pressure distribution will be.
- barbs 35 can be strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 and constrained in that position (e.g., via a removable retaining tab 40 , FIGS.
- Barbs 35 can be constrained in a state where they partially occupy the cannulation of intramedullary fusion device 5 (i.e., where barbs 35 are constrained to a point past parallel to the longitudinal axis of intramedullary fusion device 5 ), thereby further reducing the cross-sectional area of second barbed region 15 . This is beneficial for accessing the intramedullary canal through a small drilled hole.
- FIG. 1 illustrates a device with four barbs 35 on the second barbed end region 15
- second barbed end region 15 can be made with more or fewer barbs.
- barbs 35 are allowed to flare outward, whereby to grip the side wall of the drilled hole and intramedullary canal receiving second barbed end region 15 , whereby to lock second barbed end region 15 to a bone fragment via an expansive force on the intramedullary canal, as will also hereinafter be discussed.
- barbs 35 of second barbed end region 15 are separated from one another by relatively small longitudinal gaps when barbs 35 are strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 , such that barbs 35 collectively provide a substantially full circumferential structure for second barbed end region 15 (i.e., when barbs 35 are strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 , barbs 35 collectively provide a substantially continuous extension of central bridge region 20 of intramedullary fusion device 5 ). See FIGS. 3 and 4 .
- first barbed end region 10 and second barbed end region 15 may have different numbers of barbs, e.g., first barbed end region 10 may comprise four barbs 25 and second barbed end region 15 may comprise three barbs 35 .
- the barbs 25 of first barbed end region 10 preferably engage the surrounding bone about the full circumference of the intramedullary fusion device
- the barbs 35 of second barbed end region 15 preferably engage the surrounding bone about the full circumference of the intramedullary fusion device.
- Central bridge region 20 preferably comprises a generally cylindrical shape and is preferably sized so as to have an outer diameter somewhat less than the major diameters of first barbed end region 10 and second barbed end region 15 when their barbs 25 , 35 , respectively, have been strained to a position parallel to the longitudinal axis of intramedullary fusion device 5 .
- Intramedullary fusion device 5 may be used to secure together two bone fragments under compression.
- intramedullary fusion device 5 may be used to treat a hammer toe deformity ( FIG. 5 ).
- the distal end of the metatarsal 50 is cut off to correct the deformity and create a bone face 55 suitable for fusion ( FIGS. 6 and 7 ). Then the proximal end of the phalange 60 is removed to correct the deformity and create a bone face 65 suitable for fusion ( FIGS. 7 and 8 ). With these two cuts complete, the bones of the metatarsal-phalange joint can be properly aligned ( FIG. 8 ) for subsequent fusion, as will hereinafter be discussed.
- k-wire 70 passes down the intramedullary canals of phalange 60 and metatarsal 50 .
- k-wire 70 passes down the intramedullary canals of phalange 60 and metatarsal 50 .
- Removal of k-wire 70 leaves a canal 75 (i.e., the opened intramedullary canal) in phalange 60 and a canal 80 in metatarsal 50 , with canal 75 in phalange 60 being aligned with canal 80 in metatarsal 50 when phalange 60 is aligned with metatarsal 50 ( FIG. 10 ).
- Canals 75 and 80 receive intramedullary fusion device 5 as will hereinafter be discussed.
- phalange 60 is flexed downward so as to expose the prepared metatarsal face 55 ( FIG. 11 ).
- intramedullary fusion device 5 has its first barbed end region 10 advanced into canal 80 of metatarsal 50 ( FIG. 12 ). Then removable retaining tab 30 is removed, allowing barbs 25 of first barbed end region 10 to expand outwardly and grip the side wall of canal 80 , whereby to securely fasten intramedullary fusion device 5 to metatarsal 50 through an expansive force against the intramedullary surface ( FIG. 13 ).
- Phalange 60 is then pressed over second barbed region 15 of intramedullary fusion device 5 , with second barbed region 15 being received in canal 75 of phalange 60 ( FIG. 14 ). This action brings face 65 of phalange 60 against face 55 of metatarsal 50 , with just enough room being left for retaining tab 40 to extend from intramedullary device 5 to a region outside of the bone.
- retaining tab 40 is removed so that barbs 35 of second barbed end region 15 are allowed to expand outwardly and grip the side wall of canal 75 of phalange 60 ( FIG. 15 ).
- barbs 25 of first barbed end region 10 are securely engaging metatarsal 50
- barbs 35 of second barbed end region 15 are securely engaging phalange 60 , with central bridge region 20 extending across the fracture line.
- a force can be applied to reduce any gap left after removing retaining tab 40 .
- novel intramedullary fusion device 5 can first be implanted into phalange 60 and then implanted into metatarsal 50 if the surgeon so chooses.
- central bridge region 20 may have an enlargement 83 intermediate its length to act as a stop, limiting how far intramedullary fusion device 5 can be pushed into either side of the intramedullary canal during implantation.
- barbs 25 of first barbed end region 10 are shown as being circumferentially offset from barbs 35 of second barbed end region 15 , i.e., barbs 25 and barbs 35 are not axially aligned with one another. However, if desired, and looking now at FIG. 15B , barbs 25 of first barbed end region 10 may not be circumferentially offset from barbs 35 of second barbed end region 15 , i.e., barbs 25 and barbs 35 may be axially aligned with one another in the manner shown in FIG. 15B .
- intramedullary fusion device 5 can have a slight bend from central bridge region 20 to one or both of its first barbed end region 10 and second barbed end region 15 .
- intramedullary fusion device 5 may be bent after machining and during the working of the shape memory material, e.g., it may be shape-set at the desired angulation through heat treatment.
- central bridge region 20 can be processed so as to be malleable (i.e., to take a set).
- the barb regions 10 and 15 can be superelastic while central bridge region 20 can be fully annealed Nitinol or martensitic Nitinol, such that central bridge region 20 is malleable and can take a set. This allows the surgeon to deform central bridge region 20 at the time of surgery so that it assumes the bend desired.
- an intramedullary fusion system 85 which generally comprises an intramedullary fusion device 90 , an internal restrainer 95 and a locking pin 100 .
- Intramedullary fusion device 90 is manufactured from a shape memory material (e.g., a material capable of exhibiting superelasticity and/or a temperature-induced shape change).
- the shape memory material may be a metal alloy (e.g., Nitinol) or a polymer (e.g., appropriately processed PEEK).
- intramedullary fusion device 90 comprises a first barbed end region 105 , a second barbed end region 110 , and a central bridge region 115 connecting first barbed end region 105 and second barbed end region 110 .
- Intramedullary fusion device 90 is preferably cannulated so as to allow the intramedullary fusion device to be installed over a k-wire if desired, while also allowing a k-wire to be passed through the device following implantation if the surgeon desires to fuse a distal or proximal joint.
- the first and second barbed regions flare outward in multiple planes, preferably engaging the surrounding bone about the full circumference of the intramedullary fusion device, thereby providing excellent torsional stability to the fusion site.
- First barbed end region 105 comprises a plurality of barbs 120 which, in their unbiased condition, flare outward from the longitudinal axis of intramedullary fusion device 90 in the manner shown in FIG. 20 .
- the flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable first barbed end region 105 to better engage the “hourglass-shaped” intramedullary canal. The better that first barbed region 105 engages the intramedullary canal, the more even the pressure distribution will be. While FIG. 20 illustrates a device with four barbs 120 in first barbed end region 105 , it should be appreciated that the device can have more or fewer barbs.
- Barbs 120 can be strained to a position parallel to the longitudinal axis of intramedullary fusion device 90 , e.g., during insertion into a hole drilled in bone. Once inserted into the intramedullary canal, barbs 120 flare outwardly so as to engage with the side wall of the drilled hole receiving first barbed end region 105 . By angling barbs 120 relative to the longitudinal axis of intramedullary fusion device 90 , i.e., with an arrowhead configuration, barbs 120 can ensure that first barbed end region 105 is insertable into a hole in a bone but not withdrawable from the hole in the bone. In this way barbs 120 can selectively lock first barbed end region 105 to a bone fragment, as will hereinafter be discussed.
- Second barbed end region 110 comprises a plurality of barbs 125 , which, in their unbiased condition, flare outward from the longitudinal axis of intramedullary fusion device 90 in the manner shown in FIG. 20 .
- the flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable second barbed end region 110 to better engage the “hourglass-shaped” intramedullary canal. The better that second barbed region 110 engages the intramedullary canal, the more even the pressure distribution will be. While FIG. 20 illustrates a device with four barbs 125 in second barbed end region 125 , it should be appreciated that the device can have more or fewer barbs.
- Barbs 125 can be strained to a position parallel to the longitudinal axis of intramedullary fusion device 90 , e.g., during insertion into a hole drilled in bone, with barbs 125 flaring outwardly so as to remain in constant engagement with the side wall of the drilled hole receiving second barbed end region 110 .
- barbs 125 can ensure that second barbed end region 110 is insertable into a hole in a bone but not withdrawable from the hole in the bone. In this way barbs 125 can selectively lock second barbed end region 110 in the intramedullary canal of a bone fragment, as will hereinafter be discussed.
- barbs 120 of first barbed end region 105 are flared in a direction which is opposite to that of barbs 125 of second barbed end region 110 .
- Central bridge region 115 preferably comprises a generally cylindrical shape and is configured so that it can be selectively strained (i.e., stretched) longitudinally and constrained in that position (e.g., via the aforementioned internal restrainer 95 and locking pin 100 ). As will hereinafter be discussed, upon removing locking pin 100 , internal restrainer 95 will release the constraint on central bridge region 115 , whereupon central bridge region 115 will attempt to foreshorten. As will also hereinafter be discussed, this foreshortening can be harnessed to apply compression between two bone fragments.
- intramedullary fusion device 90 preferably comprises cutouts 130 , disposed in first barbed end region 105 and second barbed end region 110 , that allow central bridge region 115 to be constrained in its longitudinally stretched state by internal restrainer 95 , as will hereinafter be discussed.
- Internal restrainer 95 is shown in further detail in FIG. 22 .
- Internal restrainer 95 may comprise a shape memory material if desired.
- Internal restrainer 95 generally comprises a cannulated cylindrical body 140 terminating in a pair of fingers 145 at each end of cylindrical body 140 .
- Each pair of fingers 145 are normally biased together, however, they may be elastically forced apart so that they extend outboard beyond the circumference of cylindrical body 140 , whereby to allow fingers 145 of internal restrainer 90 to lock to cutouts 130 of intramedullary fusion device 90 when intramedullary fusion device 90 is in its longitudinally stretched state, as will hereinafter be discussed.
- central bridge region 115 of intramedullary fusion device 90 can be strained (i.e., longitudinally stretched), locked in that position via internal restrainer 95 and locking pin 100 and, upon removing locking pin 100 , internal restrainer 95 will release the constraint on central bridge region 115 of intramedullary fusion device 90 , whereupon central bridge region 115 will attempt to foreshorten. More particularly, and looking now at FIGS. 23-25 , central bridge region 115 is stretched using a stretching mechanism (not shown) of the sort which will be apparent to those skilled in the art in view of the present disclosure, and internal restrainer 95 is inserted into intramedullary fusion device 90 .
- Intramedullary fusion system 85 may be used to secure together two bone fragments and apply compression to the fracture line.
- intramedullary fusion system 85 may be used to treat a hammertoe deformity ( FIG. 26 ).
- the distal end of metatarsal 50 is cut off to correct the deformity and create a bone face 55 suitable for fusion ( FIGS. 27 and 28 ). Then the proximal end of phalange 60 is removed to correct the deformity and create a bone face 65 suitable for fusion ( FIGS. 28 and 29 ). With these two cuts complete, the bones of the metatarsal-phalange joint can be properly aligned ( FIG. 29 ) for subsequent fusion, as will hereinafter be discussed.
- k-wire 70 passes down the intramedullary canals of phalange 60 and metatarsal 50 .
- k-wire 70 passes down the intramedullary canals of phalange 60 and metatarsal 50 .
- Removal of k-wire 70 leaves a canal 75 (i.e., the opened intramedullary canal) in phalange 60 and a canal 80 in metatarsal 50 , with canal 75 in phalange 60 being aligned with canal 80 in metatarsal 50 when phalange 60 is aligned with metatarsal 50 ( FIG. 31 ).
- Canals 75 and 80 receive intramedullary fusion system 85 as will hereinafter be discussed.
- phalange 60 is flexed downward so as to expose the prepared metatarsal face 55 ( FIG. 32 ).
- Intramedullary fusion device 90 which has previously been strained (i.e., its central bridge region 115 longitudinally stretched) and locked in this state with internal restrainer 95 and locking pin 100 , is then implanted into canal 75 in phalange 60 ( FIG. 33 ), i.e., by advancing the free end of locking pin 100 and second barbed end region 110 of intramedullary fusion device 90 into canal 75 of phalange 60 .
- the flare on barbs 125 of second barbed end region 110 is such that intramedullary fusion device 90 can be advanced into canal 75 of phalange 60 but not withdrawn.
- the free end of locking pin 100 extends completely out of phalange 60 and any adjacent bone structure(s) so that it is graspable by the surgeon and able to be retracted when desired through the distal end of the toe.
- Phalange 60 is then reoriented so that first barbed end region 105 is aligned with canal 80 in metatarsal 50 , and then phalange 60 is advanced towards metatarsal 50 so that first barbed end region 105 enters canal 80 of metatarsal 50 ( FIG. 34 ).
- the flare on barbs 120 of first barbed end region 105 of intramedullary fusion device 90 is such that intramedullary fusion device 90 can be advanced into canal 80 of metatarsal 50 but not withdrawn.
- Phalange 60 is advanced towards metatarsal 50 until face 65 of phalange 60 engages face 55 of metatarsal 50 . At this point barbs 120 of first barbed end region 105 and barbs 125 of second barbed end region 110 prevent phalange 60 and metatarsal 50 from moving apart.
- intramedullary fusion device 90 With intramedullary fusion device 90 firmly secured to both phalange 60 and metatarsal 50 , locking pin 100 is then removed from internal restrainer 95 ( FIG. 35 ), i.e., by being retracted through the distal end of the toe. This allows the pairs of fingers 145 disposed on each end of internal restrainer 95 to retract from cutouts 130 of intramedullary fusion device 90 , which allows central bridge region 115 of intramedullary fusion device 90 to foreshorten, whereby to generate compression between metatarsal 50 and phalange 60 ( FIG. 36 ).
- internal restrainer 95 may be left in place within intramedullary fusion device 90 or, more preferably, internal restrainer 95 may be removed from intramedullary fusion device 90 after intramedullary fusion device 90 has been set, e.g., by grasping internal restrainer 95 with a grasping tool and drawing internal restrainer 95 longitudinally out of intramedullary fusion device 90 and then out canal 75 of phalange 60 .
- internal restrainer 95 can be automatically removed from intramedullary fusion device 90 when locking pin 100 is removed from internal restrainer 95 , e.g., by providing the distal end of locking pin 100 and the proximal end of internal restrainer 95 with an appropriate “catch mechanism” so that the retreating locking pin 100 engages internal restrainer 95 and carries internal restrainer 95 out of intramedullary fusion device 90 and then out canal 75 of phalange 60 .
- intramedullary fusion device 90 can have a slight bend at one or both of its first barbed end region 105 and second barbed end region 110 .
- intramedullary fusion device 90 may be bent after machining and during the working of the shape memory material, e.g., it may be shape-set at the desired angulation through heat treatment.
- Intramedullary fusion device 90 is specifically engineered so not to “tear through” the bone tissue when central bridge region 115 foreshortens.
- the compressive forces of intramedullary fusion device 90 can be controlled by modulating the material properties of the intramedullary fusion device and/or the geometry of the intramedullary fusion device.
- the percentage of cold work in the shape memory material forming intramedullary fusion device 90 affects the compressive force generated by the intramedullary fusion device. As the percentage of cold work increases, the compression force declines.
- the intramedullary fusion device should, preferably, have between about 15% and 55% cold work to control the recovery force of the intramedullary device.
- Another material property that affects the intramedullary fusion device's compression force is the temperature differential between the body that the intramedullary fusion device will be implanted into (assumed to be 37° C., which is the temperature of a human body) and the austenite finish temperature of the shape memory material forming intramedullary fusion device 90 .
- a smaller temperature differential between the two will result in the intramedullary fusion device generating a small compressive load; conversely, the larger the temperature differential between the two will result in the intramedullary device generating a larger compressive load.
- the shape memory material that the intramedullary fusion device is made out of should, preferably, have an austenite finish temperature of greater than about ⁇ 10° C., resulting in a temperature differential of less than about 47° C. when the intramedullary fusion device is implanted (assuming that the intramedullary fusion device is implanted in a human body).
- the geometry of the intramedullary fusion device also affects the compression force generated.
- the cross-sectional area of the hollow central bridge region 115 affects the compression force. As the cross-sectional area increases, so does the compression force that the intramedullary fusion device 90 will generate. In this respect it should be appreciated that it is beneficial for the compression force generated by the foreshortening of intramedullary fusion device 90 to be constant as the bone relaxes and remodels.
- the cross-section of hollow central bridge region 115 of intramedullary fusion device 90 preferably has a constant cross-section over its entire length. Cross-sections that are not uniform over the length of hollow central bridge region 115 can result in an increase or decrease in compression as the intramedullary fusion device foreshortens.
- the barbs 120 , 125 are important for transmitting the compression force to the bone without “tearing through” the bone.
- the height, width, and number of barbs 120 , 125 on the intramedullary device 90 are all important to the intramedullary device's ability to not “tear through” the bone.
- shape memory material can be processed to exhibit two-way shape memory.
- the intramedullary fusion device 90 can be trained to have an austenitic shape (i.e., barbs expanded) and a martensitic shape (i.e., barbs extending parallel to the longitudinal axis of intramedullary fusion device 90 ).
- the barbs can be in their austenitic shape at about body temperature.
- the barbs can be deformed via the creation of stress induced martensite to implant the intramedullary fusion device.
- the intramedullary fusion device may be cooled (e.g., with cold saline) to a temperature below the austenite start temperature of the shape memory material, and more preferably below the martensite start temperature of the shape memory material, and most preferably below the martensite finish temperature of the shape memory material.
- the intramedullary fusion device 90 will take on its martensitic shape (i.e., the barbs laying parallel to the longitudinal axis of the intramedullary fusion device), and the surgeon can easily remove the intramedullary fusion device.
- the intramedullary fusion device can be made such that central bridge region 115 of intramedullary fusion device 90 has one austenite start temperature, and such that barbs 120 , 125 have a lower austenite start temperature.
- the intramedullary fusion device can be stretched at a temperature less than the austenite start temperature of central bridge region 115 but above the austenite start temperature of barbs 120 , 125 .
- barbs 120 , 125 will be in the austenite phase and able to undergo a stress induced martensite transformation during insertion of intramedullary fusion device 90 into a bone canal.
- central bridge region 115 Maintaining the intramedullary fusion device at a temperature below the austenite start temperature of central bridge region 115 allows the intramedullary fusion device to remain in its elongated state. The intramedullary fusion device can then be advanced into a bone canal as discussed above.
- central bridge region 115 warms (either to body temperature, or to a temperature above body temperature, e.g., through the application of warm saline), central bridge region 115 will foreshorten, generating and maintaining compression across the fracture line.
- central bridge region 115 of intramedullary fusion device 90 can be processed so as to be malleable (i.e., to take a set).
- first barbed end region 105 and second barbed end region 110 can be superelastic while central bridge region 115 can be fully annealed Nitinol or martensitic Nitinol. This allows the surgeon to deform the implant at the time of surgery to the bend desired.
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This patent application is a continuation of U.S. patent application Ser. No. 15/653,902 filed Jul. 19, 2017, now U.S. Pat. No. 10,603,088 granted on Mar. 31, 2020; which is a continuation of U.S. patent application Ser. No. 14/541,017 filed Nov. 13, 2014, now U.S. Pat. No. 9,724,138 granted on Aug. 8, 2017; which is a continuation-in-part of U.S. patent application Ser. No. 13/624,643 filed Sep. 21, 2012, now U.S. Pat. No. 9,283,066 granted on Mar. 15, 2016; which claims the benefit of prior U.S. Provisional Patent Application No. 61/537,766, filed Sep. 22, 2011, and U.S. Provisional Patent Application Ser. No. 61/570,091, filed Dec. 13, 2011. U.S. application Ser. No. 14/541,017 claims priority to U.S. Provisional Patent Application No. 61/903,820 filed Nov. 13, 2013.
- The present invention relates to devices and methods for generating, applying, and maintaining compression to a site in a human or animal body in order to effect healing of diseased or damaged tissue. The invention finds particular utility in the field of orthopedics and specifically for generating and maintaining compression between bone fragments that are to be fused. While the invention has application throughout the body, its utility will be illustrated herein in the context of the repair of injured bone tissue, such as the proximal and distal interphalangeal joint of the second, third, or fourth toe and/or fingers. Additionally, the invention has application to aid in the fusion of broken ribs, etc.
- In the field of orthopedic surgery it is common to rejoin broken bones. The success of the surgical procedure often depends on the successful re-approximation of the bone fragments, the amount of compression achieved between the bone fragments, and the ability to maintain that compression between the bone fragments. If the surgeon is unable to bring the bone fragments into close contact, a gap will exist between the bone fragments and the bone tissue will need to fill that gap before complete healing can take place. Furthermore, gaps between bone fragments that are too large allow motion to occur between the bone fragments, disrupting the healing tissue and thus slowing the healing process. Optimal healing requires that the bone fragments be in close contact with each other, and for a compressive load to be applied and maintained between the bone fragments. Compressive strain between bone fragments has been found to accelerate the healing process in accordance with Wolf's Law.
- Broken bones can be rejoined using screws, staples, plates, pins, intramedullary devices, and other devices known in the art. These devices are designed to assist the surgeon with reducing the fracture and creating a compressive load between the bone fragments. Intramedullary devices are often used for fractures of the long bones; however, they are also frequently used in the phalanges and specifically for the treatment of “hammer toe”, which is a deformity of the proximal interphalangeal joint of the second, third, or fourth toe causing the toe to be permanently bent. Typical intramedullary devices used in the phalanges have opposing ends that are adapted to grip against the wall of the intramedullary canal. These intramedullary devices are typically made of titanium alloys, stainless steel alloys, Nitinol and other materials, e.g., PEEK. The titanium alloy devices and stainless steel alloy devices often have barbs or threaded regions at their opposing ends to grip the wall of the intramedullary canal. The Nitinol devices typically have a pair of radially extending “legs” at their opposing ends that expand outward when warmed to body temperature, with the pair of legs at each end being disposed in a common plane.
- While these intramedullary devices are designed to bring the bone fragments into close contact and to generate a compressive load between the bone fragments, these devices do not always succeed in accomplishing this objective. It is widely reported that the compressive load dissipates rapidly as the bone relaxes and remodels. Furthermore, gripping the bone with only a pair of co-planar legs does not provide significant torsional stability to the fusion site.
- Thus there exists a clinical need for intramedullary devices that are better able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs.
- The present invention comprises the provision and use of novel intramedullary devices that are better able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs.
- In one preferred form of the invention, there is provided apparatus for securing a first bone fragment to a second bone fragment, the apparatus comprising: a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the first end of the shaft may be advanced into a hole in the first bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft but is prevented from being withdrawn from the hole in the first bone fragment when the at least one barb is in its unbiased condition; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the second end of the shaft may be advanced into a hole in the second bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, but is prevented from being withdrawn from the hole in the second bone fragment when the at least one barb is in its unbiased condition.
- In another preferred form of the invention, there is provided a method for securing a first bone fragment to a second bone fragment, the method comprising: providing a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the first end of the shaft may be advanced into a hole in the first bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft but is prevented from being withdrawn from the hole in the first bone fragment when the at least one barb is in its unbiased condition; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, such that the second end of the shaft may be advanced into a hole in the second bone fragment when the at least one barb is elastically constrained to a position substantially parallel to the longitudinal axis of the shaft but is prevented from being withdrawn from the hole in the second bone fragment when the at least one barb is in its unbiased condition; elastically constraining the at least one barb of the first bone-engaging feature to a position substantially parallel to the longitudinal axis of the shaft, and elastically constraining the at least one barb of the second bone-engaging feature to a position substantially parallel to the longitudinal axis of the shaft; advancing the first bone-engaging feature into a hole in the first bone fragment, and advancing the second bone-engaging feature into a hole in the second bone fragment; and releasing the constraint on the at least one barb of the first bone-engaging feature and releasing the constraint on the at least one barb of the second bone-engaging feature, whereby to generate and maintain compression between the first bone fragment and the second bone fragment.
- In another preferred form of the invention, there is provided apparatus for securing a first bone fragment to a second bone fragment, the apparatus comprising: a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the first end of the shaft may be advanced into a hole in the first bone fragment but prevents the first end of the shaft from being withdrawn from the hole in the first bone fragment; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the second end of the shaft may be advanced into a hole formed in the second bone fragment but prevents the second end of the shaft from being withdrawn from the hole in the second bone fragment; wherein at least a portion of the shaft disposed between the first bone-engaging feature and the second bone-engaging feature is capable of being elastically stretched; and a holding element connectable to the fusion device for releasably holding the at least a portion of the shaft in a stretched condition.
- In another preferred form of the invention, there is provided a method for securing a first bone fragment to a second bone fragment, the method comprising: providing a fusion device, the fusion device comprising: a shaft having a first end and a second end; a first bone-engaging feature formed on the shaft at a first location, the first bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the first end of the shaft may be advanced into a hole in the first bone fragment but prevents the first end of the shaft from being withdrawn from the hole in the first bone fragment; and a second bone-engaging feature formed on the shaft at a second location, the second bone-engaging feature comprising at least one barb which, in its unbiased condition, flares outwardly from the longitudinal axis of the shaft and which is capable of being elastically constrained to a position substantially parallel to the longitudinal axis of the shaft, the at least one barb being configured so that the second end of the shaft may be advanced into a hole formed in the second bone fragment but prevents the second end of the shaft from being withdrawn from the hole in the second bone fragment; wherein at least a portion of the shaft disposed between the first bone-engaging feature and the second bone-engaging feature is capable of being elastically stretched; longitudinally stretching the fusion device so that the fusion device is in a longitudinally stretched condition; holding the fusion device in its longitudinally stretched condition; inserting the fusion device into a hole in the first bone fragment while the fusion device is in its longitudinally stretched condition, and inserting the fusion device into a hole in the second bone fragment while the fusion device is in its longitudinally stretched condition; and releasing the fusion device from its longitudinally stretched condition so as to apply compression between the first bone fragment and the second bone fragment.
- These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts, and further wherein:
-
FIGS. 1-4 are schematic views showing an intramedullary fusion device formed in accordance with the present invention; -
FIG. 4A is a schematic view showing removable retaining tabs which may be used to hold the first and second barbed end regions of the intramedullary fusion device ofFIGS. 1-4 in their radially constrained condition; -
FIGS. 5-15 are schematic views showing the novel intramedullary fusion device ofFIGS. 1-4 being used to treat a hammer toe condition; -
FIG. 15A is a schematic view showing another intramedullary fusion device formed in accordance with the present invention; -
FIG. 15B is a schematic view showing another intramedullary fusion device formed in accordance with the present invention; -
FIGS. 16-18 are schematic views showing another intramedullary fusion device formed in accordance with the present invention; -
FIGS. 19-25 are schematic views showing an intramedullary fusion system formed in accordance with the present invention; -
FIGS. 26-36 are schematic views showing the novel intramedullary fusion system ofFIGS. 19-25 being used to treat a hammer toe condition; and -
FIG. 37 is a schematic view showing another intramedullary fusion device formed in accordance with the present invention and which may be used with the intramedullary fusion system shown inFIGS. 19-25 . - The present invention comprises the provision and use of novel intramedullary devices that are better able to bring bone fragments into close proximity with each other, generate a compressive load, and maintain that compressive load for a prolonged period of time while healing occurs.
- Looking first at
FIGS. 1-4 , there is shown anintermedullary fusion device 5 manufactured from a shape memory material (e.g., a material capable of exhibiting superelasticity and/or a temperature-induced shape change). The shape memory material may be a metal alloy (e.g., Nitinol) or a polymer (e.g., appropriately processed PEEK).Intramedullary fusion device 5 comprises a firstbarbed end region 10, a secondbarbed end region 15, and acentral bridge region 20 connecting firstbarbed end region 10 to secondbarbed end region 15.Intramedullary fusion device 5 is preferably cannulated so as to allow the intramedullary fusion device to be installed over a k-wire if desired, while also allowing a k-wire to be passed through the intramedullary fusion device following implantation if the surgeon desires to fuse a distal or proximal joint. The first and second barbed regions flare outward in multiple planes, preferably engaging the surrounding bone about the full circumference of the intramedullary fusion device, thereby providing excellent torsional stability to the fusion site. - First barbed
end region 10 comprises a plurality ofbarbs 25 which, in their unbiased condition, flare outward from the longitudinal axis ofintramedullary fusion device 5 in the manner shown inFIG. 1 . The flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable firstbarbed end region 10 to better engage the “hourglass-shaped” intramedullary canal. The better that firstbarbed end region 10 engages the intramedullary canal, the more even the pressure distribution will be. However,barbs 25 can be strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5 and constrained in that position (e.g., via aremovable retaining tab 30,FIGS. 2 and 4A ) so as to reduce the cross-sectional profile of firstbarbed end region 10, whereby to allow for insertion into a drilled hole in bone, as will hereinafter be discussed.Barbs 25 can be constrained in a state where they partially occupy the cannulation of intramedullary fusion device 5 (i.e., wherebarbs 25 are strained to a point past parallel to the longitudinal axis of intramedullary fusion device 5), thereby further reducing the cross-sectional area of firstbarbed end region 10. This is beneficial for accessing the intramedullary canal through a small drilled hole. - While
FIG. 1 illustrates a device with fourbarbs 25 on firstbarbed end region 10, it should be appreciated that firstbarbed end region 10 can be made with more or fewer barbs. Upon removing retainingtab 30,barbs 25 are allowed to flare outward again, whereby to grip the side wall of the drilled hole and intramedullary canal receiving firstbarbed end region 10, whereby to lock firstbarbed end region 10 to a bone fragment via an expansive force on the intramedullary canal, as will also hereinafter be discussed. - In one preferred form of the invention,
barbs 25 of firstbarbed end region 10 are separated from one another by relatively small longitudinal gaps whenbarbs 25 are strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5, such thatbarbs 25 collectively provide a substantially full circumferential structure for first barbed end region 10 (i.e., whenbarbs 25 are strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5,barbs 25 collectively provide a substantially continuous extension ofcentral bridge region 20 of intramedullary fusion device 5). SeeFIGS. 3 and 4 . - Second
barbed end region 15 comprises a plurality ofbarbs 35 which, in their unbiased condition, flare outward from the longitudinal axis ofintramedullary fusion device 5 in the manner shown inFIG. 1 . The flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable secondbarbed end region 15 to better engage the “hourglass-shaped” intramedullary canal. The better that secondbarbed end region 15 engages the intramedullary canal, the more even the pressure distribution will be. However,barbs 35 can be strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5 and constrained in that position (e.g., via aremovable retaining tab 40,FIGS. 2 and 4A ) so as to reduce the cross-sectional profile of secondbarbed end region 15, whereby to allow for insertion into a drilled hole in bone, as will hereinafter be discussed.Barbs 35 can be constrained in a state where they partially occupy the cannulation of intramedullary fusion device 5 (i.e., wherebarbs 35 are constrained to a point past parallel to the longitudinal axis of intramedullary fusion device 5), thereby further reducing the cross-sectional area of secondbarbed region 15. This is beneficial for accessing the intramedullary canal through a small drilled hole. - While
FIG. 1 illustrates a device with fourbarbs 35 on the secondbarbed end region 15, it should be appreciated that secondbarbed end region 15 can be made with more or fewer barbs. Upon removing retainingtab 40,barbs 35 are allowed to flare outward, whereby to grip the side wall of the drilled hole and intramedullary canal receiving secondbarbed end region 15, whereby to lock secondbarbed end region 15 to a bone fragment via an expansive force on the intramedullary canal, as will also hereinafter be discussed. - In one preferred form of the invention,
barbs 35 of secondbarbed end region 15 are separated from one another by relatively small longitudinal gaps whenbarbs 35 are strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5, such thatbarbs 35 collectively provide a substantially full circumferential structure for second barbed end region 15 (i.e., whenbarbs 35 are strained to a position parallel to the longitudinal axis ofintramedullary fusion device 5,barbs 35 collectively provide a substantially continuous extension ofcentral bridge region 20 of intramedullary fusion device 5). SeeFIGS. 3 and 4 . - It should be appreciated that first
barbed end region 10 and secondbarbed end region 15 may have different numbers of barbs, e.g., firstbarbed end region 10 may comprise fourbarbs 25 and secondbarbed end region 15 may comprise threebarbs 35. However, it should be appreciated that regardless of the number ofbarbs 25 provided on firstbarbed end region 10, and regardless of the number ofbarbs 35 provided on secondbarbed end region 15, thebarbs 25 of firstbarbed end region 10 preferably engage the surrounding bone about the full circumference of the intramedullary fusion device, and thebarbs 35 of secondbarbed end region 15 preferably engage the surrounding bone about the full circumference of the intramedullary fusion device. -
Central bridge region 20 preferably comprises a generally cylindrical shape and is preferably sized so as to have an outer diameter somewhat less than the major diameters of firstbarbed end region 10 and secondbarbed end region 15 when theirbarbs intramedullary fusion device 5. -
Intramedullary fusion device 5 may be used to secure together two bone fragments under compression. By way of example but not limitation, and looking now atFIGS. 5-15 ,intramedullary fusion device 5 may be used to treat a hammer toe deformity (FIG. 5 ). - First the distal end of the
metatarsal 50 is cut off to correct the deformity and create abone face 55 suitable for fusion (FIGS. 6 and 7 ). Then the proximal end of thephalange 60 is removed to correct the deformity and create abone face 65 suitable for fusion (FIGS. 7 and 8 ). With these two cuts complete, the bones of the metatarsal-phalange joint can be properly aligned (FIG. 8 ) for subsequent fusion, as will hereinafter be discussed. - Next, the surgeon inserts a k-
wire 70 through the distal end of the toe,phalange 60 and into the metatarsal 50 (FIG. 9 ). Preferably k-wire 70 passes down the intramedullary canals ofphalange 60 andmetatarsal 50. Removal of k-wire 70 leaves a canal 75 (i.e., the opened intramedullary canal) inphalange 60 and acanal 80 inmetatarsal 50, withcanal 75 inphalange 60 being aligned withcanal 80 inmetatarsal 50 whenphalange 60 is aligned with metatarsal 50 (FIG. 10 ).Canals intramedullary fusion device 5 as will hereinafter be discussed. - Following removal of k-
wire 70,phalange 60 is flexed downward so as to expose the prepared metatarsal face 55 (FIG. 11 ). - Next, with retaining
tabs barbs barbed end region 10 and secondbarbed end region 15, respectively, to their “inboard” position (i.e., as shown inFIG. 2 ),intramedullary fusion device 5 has its firstbarbed end region 10 advanced intocanal 80 of metatarsal 50 (FIG. 12 ). Then removable retainingtab 30 is removed, allowingbarbs 25 of firstbarbed end region 10 to expand outwardly and grip the side wall ofcanal 80, whereby to securely fastenintramedullary fusion device 5 tometatarsal 50 through an expansive force against the intramedullary surface (FIG. 13 ).Phalange 60 is then pressed over secondbarbed region 15 ofintramedullary fusion device 5, with secondbarbed region 15 being received incanal 75 of phalange 60 (FIG. 14 ). This action bringsface 65 ofphalange 60 againstface 55 ofmetatarsal 50, with just enough room being left for retainingtab 40 to extend fromintramedullary device 5 to a region outside of the bone. - Next, retaining
tab 40 is removed so thatbarbs 35 of secondbarbed end region 15 are allowed to expand outwardly and grip the side wall ofcanal 75 of phalange 60 (FIG. 15 ). At thispoint barbs 25 of firstbarbed end region 10 are securely engagingmetatarsal 50, andbarbs 35 of secondbarbed end region 15 are securely engagingphalange 60, withcentral bridge region 20 extending across the fracture line. A force can be applied to reduce any gap left after removing retainingtab 40. - It should be appreciated that novel
intramedullary fusion device 5 can first be implanted intophalange 60 and then implanted intometatarsal 50 if the surgeon so chooses. - If desired, and looking now at
FIG. 15A ,central bridge region 20 may have anenlargement 83 intermediate its length to act as a stop, limiting how farintramedullary fusion device 5 can be pushed into either side of the intramedullary canal during implantation. - In
FIGS. 1-4 ,barbs 25 of firstbarbed end region 10 are shown as being circumferentially offset frombarbs 35 of secondbarbed end region 15, i.e.,barbs 25 andbarbs 35 are not axially aligned with one another. However, if desired, and looking now atFIG. 15B ,barbs 25 of firstbarbed end region 10 may not be circumferentially offset frombarbs 35 of secondbarbed end region 15, i.e.,barbs 25 andbarbs 35 may be axially aligned with one another in the manner shown inFIG. 15B . - If desired, and looking now at
FIGS. 16-18 ,intramedullary fusion device 5 can have a slight bend fromcentral bridge region 20 to one or both of its firstbarbed end region 10 and secondbarbed end region 15. By way of example but not limitation, in the metatarsal-phalange fusion shown inFIGS. 5-15 , it may be desirable to provide a slight bend to secondbarbed end region 15 so as to facilitate the restoration of the normal anatomy. In this form of the invention,intramedullary fusion device 5 may be bent after machining and during the working of the shape memory material, e.g., it may be shape-set at the desired angulation through heat treatment. - It should also be appreciated that the
central bridge region 20 can be processed so as to be malleable (i.e., to take a set). At body temperature, thebarb regions central bridge region 20 can be fully annealed Nitinol or martensitic Nitinol, such thatcentral bridge region 20 is malleable and can take a set. This allows the surgeon to deformcentral bridge region 20 at the time of surgery so that it assumes the bend desired. - Looking next at
FIG. 19 , there is shown anintramedullary fusion system 85 which generally comprises anintramedullary fusion device 90, aninternal restrainer 95 and alocking pin 100. -
Intramedullary fusion device 90 is manufactured from a shape memory material (e.g., a material capable of exhibiting superelasticity and/or a temperature-induced shape change). The shape memory material may be a metal alloy (e.g., Nitinol) or a polymer (e.g., appropriately processed PEEK). Looking now atFIGS. 20 and 21 ,intramedullary fusion device 90 comprises a firstbarbed end region 105, a secondbarbed end region 110, and acentral bridge region 115 connecting firstbarbed end region 105 and secondbarbed end region 110.Intramedullary fusion device 90 is preferably cannulated so as to allow the intramedullary fusion device to be installed over a k-wire if desired, while also allowing a k-wire to be passed through the device following implantation if the surgeon desires to fuse a distal or proximal joint. The first and second barbed regions flare outward in multiple planes, preferably engaging the surrounding bone about the full circumference of the intramedullary fusion device, thereby providing excellent torsional stability to the fusion site. - First
barbed end region 105 comprises a plurality ofbarbs 120 which, in their unbiased condition, flare outward from the longitudinal axis ofintramedullary fusion device 90 in the manner shown inFIG. 20 . The flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable firstbarbed end region 105 to better engage the “hourglass-shaped” intramedullary canal. The better that firstbarbed region 105 engages the intramedullary canal, the more even the pressure distribution will be. WhileFIG. 20 illustrates a device with fourbarbs 120 in firstbarbed end region 105, it should be appreciated that the device can have more or fewer barbs.Barbs 120 can be strained to a position parallel to the longitudinal axis ofintramedullary fusion device 90, e.g., during insertion into a hole drilled in bone. Once inserted into the intramedullary canal,barbs 120 flare outwardly so as to engage with the side wall of the drilled hole receiving firstbarbed end region 105. By anglingbarbs 120 relative to the longitudinal axis ofintramedullary fusion device 90, i.e., with an arrowhead configuration,barbs 120 can ensure that firstbarbed end region 105 is insertable into a hole in a bone but not withdrawable from the hole in the bone. In thisway barbs 120 can selectively lock firstbarbed end region 105 to a bone fragment, as will hereinafter be discussed. - Second
barbed end region 110 comprises a plurality ofbarbs 125, which, in their unbiased condition, flare outward from the longitudinal axis ofintramedullary fusion device 90 in the manner shown inFIG. 20 . The flare may increase linearly over the length of the barb, or it may increase non-linearly over the length of the barb to enable secondbarbed end region 110 to better engage the “hourglass-shaped” intramedullary canal. The better that secondbarbed region 110 engages the intramedullary canal, the more even the pressure distribution will be. WhileFIG. 20 illustrates a device with fourbarbs 125 in secondbarbed end region 125, it should be appreciated that the device can have more or fewer barbs.Barbs 125 can be strained to a position parallel to the longitudinal axis ofintramedullary fusion device 90, e.g., during insertion into a hole drilled in bone, withbarbs 125 flaring outwardly so as to remain in constant engagement with the side wall of the drilled hole receiving secondbarbed end region 110. By anglingbarbs 125 relative to the longitudinal axis ofintramedullary fusion device 90, i.e., with an arrowhead configuration,barbs 125 can ensure that secondbarbed end region 110 is insertable into a hole in a bone but not withdrawable from the hole in the bone. In thisway barbs 125 can selectively lock secondbarbed end region 110 in the intramedullary canal of a bone fragment, as will hereinafter be discussed. - Note that
barbs 120 of firstbarbed end region 105 are flared in a direction which is opposite to that ofbarbs 125 of secondbarbed end region 110. -
Central bridge region 115 preferably comprises a generally cylindrical shape and is configured so that it can be selectively strained (i.e., stretched) longitudinally and constrained in that position (e.g., via the aforementionedinternal restrainer 95 and locking pin 100). As will hereinafter be discussed, upon removinglocking pin 100,internal restrainer 95 will release the constraint oncentral bridge region 115, whereuponcentral bridge region 115 will attempt to foreshorten. As will also hereinafter be discussed, this foreshortening can be harnessed to apply compression between two bone fragments. - In order to allow
central bridge region 115 to be constrained in its longitudinally stretched state,intramedullary fusion device 90 preferably comprisescutouts 130, disposed in firstbarbed end region 105 and secondbarbed end region 110, that allowcentral bridge region 115 to be constrained in its longitudinally stretched state byinternal restrainer 95, as will hereinafter be discussed. - Internal restrainer 95 is shown in further detail in
FIG. 22 . Internal restrainer 95 may comprise a shape memory material if desired. Internal restrainer 95 generally comprises a cannulatedcylindrical body 140 terminating in a pair offingers 145 at each end ofcylindrical body 140. Each pair offingers 145 are normally biased together, however, they may be elastically forced apart so that they extend outboard beyond the circumference ofcylindrical body 140, whereby to allowfingers 145 of internal restrainer 90 to lock tocutouts 130 ofintramedullary fusion device 90 whenintramedullary fusion device 90 is in its longitudinally stretched state, as will hereinafter be discussed. - As noted above,
central bridge region 115 ofintramedullary fusion device 90 can be strained (i.e., longitudinally stretched), locked in that position viainternal restrainer 95 and lockingpin 100 and, upon removinglocking pin 100,internal restrainer 95 will release the constraint oncentral bridge region 115 ofintramedullary fusion device 90, whereuponcentral bridge region 115 will attempt to foreshorten. More particularly, and looking now atFIGS. 23-25 ,central bridge region 115 is stretched using a stretching mechanism (not shown) of the sort which will be apparent to those skilled in the art in view of the present disclosure, andinternal restrainer 95 is inserted intointramedullary fusion device 90. Asinternal restrainer 95 is inserted intointramedullary fusion device 90, the pairs offingers 145 disposed at each end ofinternal restrainer 95 are aligned withcutouts 130 in firstbarbed end region 105 and secondbarbed end region 110. Lockingpin 100 is then inserted intointernal restrainer 95, whereby to cause the pairs offingers 145 disposed at each end of internal restrainer 95 to project throughcutouts 140 ofintramedullary fusion device 90, whereby to lockcentral bridge region 115 ofintramedullary fusion device 90 in its strained (i.e., longitudinally stretched) state. The external load stretching central bridge region 105 (i.e., via the aforementioned stretching mechanism, not shown) can now be removed, andcentral bridge region 115 ofintramedullary fusion device 90 will remain in its strained (i.e., stretched) state due to the action ofinternal restrainer 95 and lockingpin 100. However, when lockingpin 100 is thereafter removed from the interior ofinternal restrainer 95, the pairs offingers 145 disposed at each end of internal restrainer 95 retract fromcutouts 130 by virtue of their inward bias, allowingcentral bridge region 115 ofintramedullary fusion device 90 to foreshorten, whereby to generate compression between the bone fragments, as will hereinafter be discussed. -
Intramedullary fusion system 85 may be used to secure together two bone fragments and apply compression to the fracture line. By way of example but not limitation, and looking now atFIGS. 26-36 ,intramedullary fusion system 85 may be used to treat a hammertoe deformity (FIG. 26 ). - First, the distal end of
metatarsal 50 is cut off to correct the deformity and create abone face 55 suitable for fusion (FIGS. 27 and 28 ). Then the proximal end ofphalange 60 is removed to correct the deformity and create abone face 65 suitable for fusion (FIGS. 28 and 29 ). With these two cuts complete, the bones of the metatarsal-phalange joint can be properly aligned (FIG. 29 ) for subsequent fusion, as will hereinafter be discussed. - Next, the surgeon inserts k-
wire 70 through the distal end of the toe, then throughphalange 60 and into metatarsal 50 (FIG. 30 ). Preferably k-wire 70 passes down the intramedullary canals ofphalange 60 andmetatarsal 50. Removal of k-wire 70 leaves a canal 75 (i.e., the opened intramedullary canal) inphalange 60 and acanal 80 inmetatarsal 50, withcanal 75 inphalange 60 being aligned withcanal 80 inmetatarsal 50 whenphalange 60 is aligned with metatarsal 50 (FIG. 31 ).Canals intramedullary fusion system 85 as will hereinafter be discussed. - Following removal of k-
wire 70,phalange 60 is flexed downward so as to expose the prepared metatarsal face 55 (FIG. 32 ). -
Intramedullary fusion device 90, which has previously been strained (i.e., itscentral bridge region 115 longitudinally stretched) and locked in this state withinternal restrainer 95 and lockingpin 100, is then implanted intocanal 75 in phalange 60 (FIG. 33 ), i.e., by advancing the free end of lockingpin 100 and secondbarbed end region 110 ofintramedullary fusion device 90 intocanal 75 ofphalange 60. Note that the flare onbarbs 125 of secondbarbed end region 110 is such thatintramedullary fusion device 90 can be advanced intocanal 75 ofphalange 60 but not withdrawn. Note also that the free end of lockingpin 100 extends completely out ofphalange 60 and any adjacent bone structure(s) so that it is graspable by the surgeon and able to be retracted when desired through the distal end of the toe. -
Phalange 60 is then reoriented so that firstbarbed end region 105 is aligned withcanal 80 inmetatarsal 50, and thenphalange 60 is advanced towardsmetatarsal 50 so that firstbarbed end region 105 enterscanal 80 of metatarsal 50 (FIG. 34 ). Note that the flare onbarbs 120 of firstbarbed end region 105 ofintramedullary fusion device 90 is such thatintramedullary fusion device 90 can be advanced intocanal 80 ofmetatarsal 50 but not withdrawn. -
Phalange 60 is advanced towardsmetatarsal 50 untilface 65 ofphalange 60 engagesface 55 ofmetatarsal 50. At thispoint barbs 120 of firstbarbed end region 105 andbarbs 125 of secondbarbed end region 110 preventphalange 60 andmetatarsal 50 from moving apart. - With
intramedullary fusion device 90 firmly secured to bothphalange 60 andmetatarsal 50, lockingpin 100 is then removed from internal restrainer 95 (FIG. 35 ), i.e., by being retracted through the distal end of the toe. This allows the pairs offingers 145 disposed on each end of internal restrainer 95 to retract fromcutouts 130 ofintramedullary fusion device 90, which allowscentral bridge region 115 ofintramedullary fusion device 90 to foreshorten, whereby to generate compression betweenmetatarsal 50 and phalange 60 (FIG. 36 ). - If desired,
internal restrainer 95 may be left in place withinintramedullary fusion device 90 or, more preferably,internal restrainer 95 may be removed fromintramedullary fusion device 90 afterintramedullary fusion device 90 has been set, e.g., by grasping internal restrainer 95 with a grasping tool and drawinginternal restrainer 95 longitudinally out ofintramedullary fusion device 90 and then outcanal 75 ofphalange 60. Alternatively,internal restrainer 95 can be automatically removed fromintramedullary fusion device 90 when lockingpin 100 is removed frominternal restrainer 95, e.g., by providing the distal end of lockingpin 100 and the proximal end of internal restrainer 95 with an appropriate “catch mechanism” so that the retreatinglocking pin 100 engagesinternal restrainer 95 and carriesinternal restrainer 95 out ofintramedullary fusion device 90 and then outcanal 75 ofphalange 60. - If desired, and looking now at
FIG. 37 ,intramedullary fusion device 90 can have a slight bend at one or both of its firstbarbed end region 105 and secondbarbed end region 110. By way of example but not limitation, in the metatarsal-phalange fusion shown inFIGS. 26-36 , it may be desirable to provide a slight bend to secondbarbed end region 110 so as to facilitate restoration of the normal anatomy. In this form of the invention,intramedullary fusion device 90 may be bent after machining and during the working of the shape memory material, e.g., it may be shape-set at the desired angulation through heat treatment. -
Intramedullary fusion device 90 is specifically engineered so not to “tear through” the bone tissue whencentral bridge region 115 foreshortens. The compressive forces ofintramedullary fusion device 90 can be controlled by modulating the material properties of the intramedullary fusion device and/or the geometry of the intramedullary fusion device. - The percentage of cold work in the shape memory material forming
intramedullary fusion device 90 affects the compressive force generated by the intramedullary fusion device. As the percentage of cold work increases, the compression force declines. The intramedullary fusion device should, preferably, have between about 15% and 55% cold work to control the recovery force of the intramedullary device. - Another material property that affects the intramedullary fusion device's compression force is the temperature differential between the body that the intramedullary fusion device will be implanted into (assumed to be 37° C., which is the temperature of a human body) and the austenite finish temperature of the shape memory material forming
intramedullary fusion device 90. A smaller temperature differential between the two will result in the intramedullary fusion device generating a small compressive load; conversely, the larger the temperature differential between the two will result in the intramedullary device generating a larger compressive load. The shape memory material that the intramedullary fusion device is made out of should, preferably, have an austenite finish temperature of greater than about −10° C., resulting in a temperature differential of less than about 47° C. when the intramedullary fusion device is implanted (assuming that the intramedullary fusion device is implanted in a human body). - The geometry of the intramedullary fusion device also affects the compression force generated. The cross-sectional area of the hollow
central bridge region 115 affects the compression force. As the cross-sectional area increases, so does the compression force that theintramedullary fusion device 90 will generate. In this respect it should be appreciated that it is beneficial for the compression force generated by the foreshortening ofintramedullary fusion device 90 to be constant as the bone relaxes and remodels. Thus, the cross-section of hollowcentral bridge region 115 ofintramedullary fusion device 90 preferably has a constant cross-section over its entire length. Cross-sections that are not uniform over the length of hollowcentral bridge region 115 can result in an increase or decrease in compression as the intramedullary fusion device foreshortens. - The
barbs barbs intramedullary device 90 are all important to the intramedullary device's ability to not “tear through” the bone. - It should also be appreciated that shape memory material can be processed to exhibit two-way shape memory. The
intramedullary fusion device 90 can be trained to have an austenitic shape (i.e., barbs expanded) and a martensitic shape (i.e., barbs extending parallel to the longitudinal axis of intramedullary fusion device 90). In this case, the barbs can be in their austenitic shape at about body temperature. The barbs can be deformed via the creation of stress induced martensite to implant the intramedullary fusion device. If the intramedullary fusion device thereafter needs to be removed, the intramedullary fusion device may be cooled (e.g., with cold saline) to a temperature below the austenite start temperature of the shape memory material, and more preferably below the martensite start temperature of the shape memory material, and most preferably below the martensite finish temperature of the shape memory material. When cooled, theintramedullary fusion device 90 will take on its martensitic shape (i.e., the barbs laying parallel to the longitudinal axis of the intramedullary fusion device), and the surgeon can easily remove the intramedullary fusion device. - Additionally, the intramedullary fusion device can be made such that
central bridge region 115 ofintramedullary fusion device 90 has one austenite start temperature, and such thatbarbs central bridge region 115 but above the austenite start temperature ofbarbs barbs intramedullary fusion device 90 into a bone canal. Maintaining the intramedullary fusion device at a temperature below the austenite start temperature ofcentral bridge region 115 allows the intramedullary fusion device to remain in its elongated state. The intramedullary fusion device can then be advanced into a bone canal as discussed above. When thecentral bridge region 115 warms (either to body temperature, or to a temperature above body temperature, e.g., through the application of warm saline),central bridge region 115 will foreshorten, generating and maintaining compression across the fracture line. - It should also be appreciated that
central bridge region 115 ofintramedullary fusion device 90 can be processed so as to be malleable (i.e., to take a set). At body temperature, firstbarbed end region 105 and secondbarbed end region 110 can be superelastic whilecentral bridge region 115 can be fully annealed Nitinol or martensitic Nitinol. This allows the surgeon to deform the implant at the time of surgery to the bend desired. - It should be understood that many additional changes in the details, materials, steps and arrangements of parts, which have been herein described and illustrated in order to explain the nature of the present invention, may be made by those skilled in the art while still remaining within the principles and scope of the invention.
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/836,124 US20200222090A1 (en) | 2011-09-22 | 2020-03-31 | Intermedullary devices for generating and applying compression within a body |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161537766P | 2011-09-22 | 2011-09-22 | |
US201161570091P | 2011-12-13 | 2011-12-13 | |
US13/624,643 US9283006B2 (en) | 2011-09-22 | 2012-09-21 | Osteosynthetic shape memory material intramedullary bone stent and method for treating a bone fracture using the same |
US201361903820P | 2013-11-13 | 2013-11-13 | |
US14/541,017 US9724138B2 (en) | 2011-09-22 | 2014-11-13 | Intermedullary devices for generating and applying compression within a body |
US15/653,902 US10603088B2 (en) | 2011-09-22 | 2017-07-19 | Intermedullary devices for generating and applying compression within a body |
US16/836,124 US20200222090A1 (en) | 2011-09-22 | 2020-03-31 | Intermedullary devices for generating and applying compression within a body |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/653,902 Continuation US10603088B2 (en) | 2011-09-22 | 2017-07-19 | Intermedullary devices for generating and applying compression within a body |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200222090A1 true US20200222090A1 (en) | 2020-07-16 |
Family
ID=52626273
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/541,017 Active US9724138B2 (en) | 2011-09-22 | 2014-11-13 | Intermedullary devices for generating and applying compression within a body |
US15/653,902 Active 2032-11-09 US10603088B2 (en) | 2011-09-22 | 2017-07-19 | Intermedullary devices for generating and applying compression within a body |
US16/836,124 Abandoned US20200222090A1 (en) | 2011-09-22 | 2020-03-31 | Intermedullary devices for generating and applying compression within a body |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/541,017 Active US9724138B2 (en) | 2011-09-22 | 2014-11-13 | Intermedullary devices for generating and applying compression within a body |
US15/653,902 Active 2032-11-09 US10603088B2 (en) | 2011-09-22 | 2017-07-19 | Intermedullary devices for generating and applying compression within a body |
Country Status (1)
Country | Link |
---|---|
US (3) | US9724138B2 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8388624B2 (en) | 2003-02-24 | 2013-03-05 | Arthrosurface Incorporated | Trochlear resurfacing system and method |
EP1765201A4 (en) | 2004-06-28 | 2013-01-23 | Arthrosurface Inc | System for articular surface replacement |
FR2884406B1 (en) | 2005-04-14 | 2008-10-17 | Memometal Technologies Soc Par | INTRAMEDULAR OSTEOSYNTHESIS DEVICE OF TWO BONE PARTS, IN PARTICULAR HAND AND / OR FOOT |
US9358029B2 (en) | 2006-12-11 | 2016-06-07 | Arthrosurface Incorporated | Retrograde resection apparatus and method |
FR2935601B1 (en) | 2008-09-09 | 2010-10-01 | Memometal Technologies | INTRAMEDULLARY IMPLANT RESORBABLE BETWEEN TWO BONE OR TWO BONE FRAGMENTS |
US9662126B2 (en) | 2009-04-17 | 2017-05-30 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
WO2016154393A1 (en) | 2009-04-17 | 2016-09-29 | Arthrosurface Incorporated | Glenoid repair system and methods of use thereof |
EP2542165A4 (en) | 2010-03-05 | 2015-10-07 | Arthrosurface Inc | Tibial resurfacing system and method |
US9724140B2 (en) | 2010-06-02 | 2017-08-08 | Wright Medical Technology, Inc. | Tapered, cylindrical cruciform hammer toe implant and method |
US8608785B2 (en) | 2010-06-02 | 2013-12-17 | Wright Medical Technology, Inc. | Hammer toe implant with expansion portion for retrograde approach |
US9498273B2 (en) | 2010-06-02 | 2016-11-22 | Wright Medical Technology, Inc. | Orthopedic implant kit |
EP2685940A4 (en) * | 2011-03-14 | 2015-01-21 | Topsfield Medical Gmbh | Implantable glenoid prostheses |
USRE49667E1 (en) * | 2011-10-10 | 2023-09-26 | William Casey Fox | Shape changing bone implant and method of use for enhancing healing |
US9554914B2 (en) * | 2011-12-12 | 2017-01-31 | Wright Medical Technology, Inc. | Fusion implant |
US20130165982A1 (en) | 2011-12-22 | 2013-06-27 | Arthrosurface Incorporated | System and Method for Bone Fixation |
WO2014008126A1 (en) | 2012-07-03 | 2014-01-09 | Arthrosurface Incorporated | System and method for joint resurfacing and repair |
US8945232B2 (en) | 2012-12-31 | 2015-02-03 | Wright Medical Technology, Inc. | Ball and socket implants for correction of hammer toes and claw toes |
US9492200B2 (en) | 2013-04-16 | 2016-11-15 | Arthrosurface Incorporated | Suture system and method |
CA2914507A1 (en) * | 2013-06-05 | 2014-12-11 | Lc Therapeutics, Inc. | Tissue anchor and deployment device for same |
US9724139B2 (en) | 2013-10-01 | 2017-08-08 | Wright Medical Technology, Inc. | Hammer toe implant and method |
WO2015061556A2 (en) * | 2013-10-23 | 2015-04-30 | Extremity Medical Llc | Devices and methods for bone fixation using an intramedullary fixation implant |
US9522022B2 (en) | 2013-11-18 | 2016-12-20 | Biomedical Enterprises, Inc. | Method and appparatus for an intramedullary implant and method of implantation therefor |
US9636155B2 (en) | 2013-11-18 | 2017-05-02 | Biomedical Enterprises, Inc. | Method and apparatus for an intramudullary implant and method of implantation thereof |
US9474561B2 (en) * | 2013-11-19 | 2016-10-25 | Wright Medical Technology, Inc. | Two-wire technique for installing hammertoe implant |
US9498266B2 (en) * | 2014-02-12 | 2016-11-22 | Wright Medical Technology, Inc. | Intramedullary implant, system, and method for inserting an implant into a bone |
US9545274B2 (en) * | 2014-02-12 | 2017-01-17 | Wright Medical Technology, Inc. | Intramedullary implant, system, and method for inserting an implant into a bone |
US10624748B2 (en) | 2014-03-07 | 2020-04-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
US9931219B2 (en) | 2014-03-07 | 2018-04-03 | Arthrosurface Incorporated | Implant and anchor assembly |
US11607319B2 (en) | 2014-03-07 | 2023-03-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
US9808296B2 (en) | 2014-09-18 | 2017-11-07 | Wright Medical Technology, Inc. | Hammertoe implant and instrument |
JP6438033B2 (en) | 2014-12-19 | 2018-12-12 | ライト メディカル テクノロジー インコーポレイテッドWright Medical Technology, Inc. | Intramedullary implant |
US9757168B2 (en) | 2015-03-03 | 2017-09-12 | Howmedica Osteonics Corp. | Orthopedic implant and methods of implanting and removing same |
US10292745B2 (en) * | 2015-10-07 | 2019-05-21 | Arthrex, Inc. | Devices for generating and applying compression within a body |
EP3383296B1 (en) * | 2015-12-03 | 2020-05-20 | Biomet Manufacturing, LLC | Hammertoe implant promoting bony in-growth |
CN113397618A (en) * | 2016-01-21 | 2021-09-17 | 克利夫兰临床基金会 | System and apparatus for assisting submucosal dissection |
FR3048871A1 (en) | 2016-03-16 | 2017-09-22 | Neosteo | MEDICAL IMPLANT AND ASSEMBLY COMPRISING SUCH A MEDICAL IMPLANT AND A PREHENDER OF SAID IMPLANT |
US20190059960A1 (en) * | 2016-03-24 | 2019-02-28 | Wright Medical Technology, Inc. | Two part hammertoe implant with expandable tines |
US10537369B1 (en) * | 2016-05-19 | 2020-01-21 | Medshape, Inc. | Bone anchor device |
FR3051350B1 (en) * | 2016-05-19 | 2021-12-10 | Fournitures Hospitalieres Ind | INTERPHALANGIAL ARTHRODESIS IMPLANT |
US10470807B2 (en) | 2016-06-03 | 2019-11-12 | Stryker European Holdings I, Llc | Intramedullary implant and method of use |
CA3033091A1 (en) | 2016-09-08 | 2018-03-15 | Meduloc, Llc | Implant and method for long bone fixation |
US10660676B2 (en) | 2017-02-20 | 2020-05-26 | Paragon 28, Inc. | Implants, devices, instruments, systems and methods of forming and implanting |
EP3592265B1 (en) | 2017-03-10 | 2023-09-20 | Paragon 28, Inc. | Bone implant devices |
EP3525727B1 (en) * | 2017-04-11 | 2023-11-29 | Waldemar Link GmbH & Co. KG | Arthrodesis plate |
US11280031B2 (en) | 2017-07-14 | 2022-03-22 | Regents Of The University Of Minnesota | Active knit compression garments, devices and related methods |
US11160663B2 (en) | 2017-08-04 | 2021-11-02 | Arthrosurface Incorporated | Multicomponent articular surface implant |
FR3072015B1 (en) * | 2017-10-09 | 2022-05-20 | Adsm | MEDICAL IMPLANT FOR ARTHRODESIS |
EP3737299B1 (en) | 2018-01-08 | 2023-09-06 | Russell D. Petranto | Flexible, cannulated implants for the hand and foot |
US10687952B2 (en) * | 2018-01-08 | 2020-06-23 | Russell D. Petranto | Flexible, cannulated implants for the hand and foot and methods of implanting flexible implants |
GB2596006B (en) | 2019-03-12 | 2022-11-30 | Arthrosurface Inc | Humeral and glenoid articular surface implant systems and methods |
WO2021231329A1 (en) | 2020-05-11 | 2021-11-18 | Gensano Llc | Cannulated bone implant |
US11317956B1 (en) | 2021-08-26 | 2022-05-03 | University Of Utah Research Foundation | Active compression bone screw |
CN115177346B (en) * | 2022-07-01 | 2023-11-03 | 无锡市第九人民医院 | Columnar elastic intramedullary nail convenient to implant and take out |
US11998255B1 (en) | 2023-08-26 | 2024-06-04 | University Of Utah Research Foundation | Cannulated continuous compression screw |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2787313A1 (en) * | 1998-12-17 | 2000-06-23 | Orsco International | Osteo-synthesis implant has shape memory material inserts to expand into contact with bone fragments |
US20090005782A1 (en) * | 2007-03-02 | 2009-01-01 | Chirico Paul E | Fracture Fixation System and Method |
WO2013055824A1 (en) * | 2011-10-10 | 2013-04-18 | William Casey Fox | Shape changing bone implant for enhanced healing |
US9138274B1 (en) * | 2012-05-04 | 2015-09-22 | Xtraverse, LLC | Fasteners with shape changing bellows and methods using same |
US20160317198A1 (en) * | 2015-04-30 | 2016-11-03 | William Casey Fox | Bone intramedullary fixation scaffold |
US20180078293A1 (en) * | 2016-09-08 | 2018-03-22 | Meduloc, Llc | Implant and method for long bone fixation |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3710789A (en) | 1970-12-04 | 1973-01-16 | Univ Minnesota | Method of repairing bone fractures with expanded metal |
US4512338A (en) | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4522200A (en) * | 1983-06-10 | 1985-06-11 | Ace Orthopedic Company | Adjustable intramedullar rod |
US4601625A (en) * | 1984-05-11 | 1986-07-22 | Illinois Tool Works Inc. | Self drilling threaded insert for drywall |
US4625722A (en) | 1985-05-03 | 1986-12-02 | Murray William M | Bone cement system and method |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
DE3640745A1 (en) | 1985-11-30 | 1987-06-04 | Ernst Peter Prof Dr M Strecker | Catheter for producing or extending connections to or between body cavities |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
US4969888A (en) | 1989-02-09 | 1990-11-13 | Arie Scholten | Surgical protocol for fixation of osteoporotic bone using inflatable device |
US4959065A (en) | 1989-07-14 | 1990-09-25 | Techmedica, Inc. | Bone plate with positioning member |
US5089006A (en) | 1989-11-29 | 1992-02-18 | Stiles Frank B | Biological duct liner and installation catheter |
US5147166A (en) * | 1990-10-22 | 1992-09-15 | Jtb, Inc. | Wall anchor |
DK0674495T3 (en) * | 1992-12-15 | 2002-03-11 | Internat Polymer Engineering I | Joint implant |
US5776140A (en) | 1996-07-16 | 1998-07-07 | Cordis Corporation | Stent delivery system |
US6068630A (en) * | 1997-01-02 | 2000-05-30 | St. Francis Medical Technologies, Inc. | Spine distraction implant |
EP1905392B1 (en) | 1997-03-07 | 2011-05-18 | Kyphon SÀRL | System for percutaneous bone and spinal stabilization, fixation and repair |
US6554833B2 (en) * | 1998-10-26 | 2003-04-29 | Expanding Orthopedics, Inc. | Expandable orthopedic device |
US8007498B2 (en) | 1999-12-09 | 2011-08-30 | Mische Hans A | Methods and devices for treatment of bone fractures |
US7976648B1 (en) | 2000-11-02 | 2011-07-12 | Abbott Cardiovascular Systems Inc. | Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite |
US7175655B1 (en) | 2001-09-17 | 2007-02-13 | Endovascular Technologies, Inc. | Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices |
US6869449B2 (en) * | 2001-10-05 | 2005-03-22 | Depuy Orthopaedics, Inc. | Prosthetic joint component having multiple arcuate bending portions |
US6761731B2 (en) | 2002-06-28 | 2004-07-13 | Cordis Corporation | Balloon-stent interaction to help reduce foreshortening |
US7025789B2 (en) * | 2003-04-29 | 2006-04-11 | The University Of Hong Kong | Prosthetic device and method for total joint replacement in small joint arthroplasty |
US7934895B2 (en) * | 2003-10-10 | 2011-05-03 | Illinois Tool Works Inc. | Self-drilling anchor |
US7762751B2 (en) * | 2004-02-05 | 2010-07-27 | Illinois Tool Works Inc. | Anchor |
DE102004009429A1 (en) * | 2004-02-24 | 2005-09-22 | Biedermann Motech Gmbh | Bone anchoring element |
US7985222B2 (en) | 2004-04-21 | 2011-07-26 | Medshape Solutions, Inc. | Osteosynthetic implants and methods of use and manufacture |
MXPA06014064A (en) * | 2004-06-02 | 2007-07-13 | Kfx Medical Corp | System and method for attaching soft tissue to bone. |
US7261505B2 (en) * | 2004-09-10 | 2007-08-28 | Illinois Tool Works Inc. | Self-drilling anchor |
JP5250260B2 (en) | 2004-10-04 | 2013-07-31 | セント・ルイス・ユニバーシティー | Intramedullary nail device and method for repairing long bones |
FR2884406B1 (en) | 2005-04-14 | 2008-10-17 | Memometal Technologies Soc Par | INTRAMEDULAR OSTEOSYNTHESIS DEVICE OF TWO BONE PARTS, IN PARTICULAR HAND AND / OR FOOT |
US8721646B2 (en) | 2006-10-10 | 2014-05-13 | William Casey Fox | Methods and apparatus for a staple |
FR2908626B1 (en) * | 2006-11-16 | 2010-01-15 | Newdeal | INTER-PHALANGEAL ARTHRODESIS IMPLANT, SURGICAL KIT AND METHOD OF MANUFACTURING THE SAME |
US20080221697A1 (en) * | 2007-03-06 | 2008-09-11 | Robert Graser | Hemi-implant for first metatarsophalangeal joint |
FR2913876B1 (en) * | 2007-03-20 | 2009-06-05 | Memometal Technologies Soc Par | OSTEOSYNTHESIS DEVICE |
US8062378B2 (en) | 2007-03-26 | 2011-11-22 | Mx Orthopedics Corp. | Proximal self-locking long bone prosthesis |
US20080269746A1 (en) | 2007-04-24 | 2008-10-30 | Osteolign, Inc. | Conformable intramedullary implant with nestable components |
CN101969867B (en) | 2008-01-14 | 2013-03-27 | 康文图斯整形外科公司 | Apparatus for fracture repair |
EP2679180A1 (en) | 2008-02-27 | 2014-01-01 | MedShape, Inc. | Intramedullary medical device and method of manufacture |
US8057147B2 (en) * | 2008-07-03 | 2011-11-15 | Illinois Tool Works Inc | Self-drilling anchor |
FR2935601B1 (en) * | 2008-09-09 | 2010-10-01 | Memometal Technologies | INTRAMEDULLARY IMPLANT RESORBABLE BETWEEN TWO BONE OR TWO BONE FRAGMENTS |
WO2010088561A2 (en) * | 2009-01-30 | 2010-08-05 | Kfx Medical Corporation | System and method for attaching soft tissue to bone |
AU2010215828A1 (en) | 2009-02-19 | 2011-09-22 | Nextremity Solutions, Llc | Bone joining apparatus and method |
FR2957244B1 (en) * | 2010-03-09 | 2012-04-13 | Synchro Medical | ARTHRODESE IMPLANT |
US8216398B2 (en) | 2010-05-17 | 2012-07-10 | Saint Louis University | Method for controlling phase transformation temperature in metal alloy of a device |
US8608785B2 (en) * | 2010-06-02 | 2013-12-17 | Wright Medical Technology, Inc. | Hammer toe implant with expansion portion for retrograde approach |
US9724140B2 (en) | 2010-06-02 | 2017-08-08 | Wright Medical Technology, Inc. | Tapered, cylindrical cruciform hammer toe implant and method |
US8834483B2 (en) * | 2010-10-04 | 2014-09-16 | Biomedical Enterprises, Inc. | Method and system for storing and inserting an implant |
US8404065B2 (en) * | 2011-06-28 | 2013-03-26 | Robert W. Miller | Method and apparatus for installing a surface conforming drywall anchor |
US20130023876A1 (en) * | 2011-07-19 | 2013-01-24 | Illuminoss Medical, Inc. | Combination Photodynamic Devices |
US10512459B2 (en) | 2011-07-27 | 2019-12-24 | William Casey Fox | Bone staple, instrument and method of use and manufacturing |
US9283006B2 (en) | 2011-09-22 | 2016-03-15 | Mx Orthopedics, Corp. | Osteosynthetic shape memory material intramedullary bone stent and method for treating a bone fracture using the same |
US8998999B2 (en) * | 2011-11-17 | 2015-04-07 | Orthohelix Surgical Designs, Inc. | Hammertoe implant |
US8764842B2 (en) | 2012-05-31 | 2014-07-01 | Michael Graham | Interphalangeal joint implant methods and apparatus |
WO2014117107A1 (en) * | 2013-01-28 | 2014-07-31 | Cartiva, Inc. | Systems and methods for orthopedic repair |
USD720072S1 (en) * | 2013-02-06 | 2014-12-23 | Biomedical Enterprises, Inc. | Orthopedic implant |
WO2015061556A2 (en) * | 2013-10-23 | 2015-04-30 | Extremity Medical Llc | Devices and methods for bone fixation using an intramedullary fixation implant |
EP2873384B1 (en) * | 2013-11-14 | 2016-10-05 | Biedermann Technologies GmbH & Co. KG | Bone anchor and bone anchoring assembly comprising the same |
US9636155B2 (en) * | 2013-11-18 | 2017-05-02 | Biomedical Enterprises, Inc. | Method and apparatus for an intramudullary implant and method of implantation thereof |
US9522022B2 (en) * | 2013-11-18 | 2016-12-20 | Biomedical Enterprises, Inc. | Method and appparatus for an intramedullary implant and method of implantation therefor |
US9545274B2 (en) * | 2014-02-12 | 2017-01-17 | Wright Medical Technology, Inc. | Intramedullary implant, system, and method for inserting an implant into a bone |
FR3018441B1 (en) * | 2014-03-11 | 2016-04-01 | Novastep | SURGICAL IMPLANT FOR MERGING BETWEEN TWO PORTIONS OF BONE AND ANCILLARY CLAMP FOR TIGHTENING SUCH A SURGICAL IMPLANT |
US9808296B2 (en) * | 2014-09-18 | 2017-11-07 | Wright Medical Technology, Inc. | Hammertoe implant and instrument |
USD745163S1 (en) * | 2014-11-13 | 2015-12-08 | Biomedical Enterprises, Inc. | Orthopedic implant |
US9757168B2 (en) * | 2015-03-03 | 2017-09-12 | Howmedica Osteonics Corp. | Orthopedic implant and methods of implanting and removing same |
-
2014
- 2014-11-13 US US14/541,017 patent/US9724138B2/en active Active
-
2017
- 2017-07-19 US US15/653,902 patent/US10603088B2/en active Active
-
2020
- 2020-03-31 US US16/836,124 patent/US20200222090A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2787313A1 (en) * | 1998-12-17 | 2000-06-23 | Orsco International | Osteo-synthesis implant has shape memory material inserts to expand into contact with bone fragments |
US20090005782A1 (en) * | 2007-03-02 | 2009-01-01 | Chirico Paul E | Fracture Fixation System and Method |
WO2013055824A1 (en) * | 2011-10-10 | 2013-04-18 | William Casey Fox | Shape changing bone implant for enhanced healing |
US10448979B2 (en) * | 2011-10-10 | 2019-10-22 | William Casey Fox | Shape changing bone implant and method of use for enhancing healing |
US9138274B1 (en) * | 2012-05-04 | 2015-09-22 | Xtraverse, LLC | Fasteners with shape changing bellows and methods using same |
US20160317198A1 (en) * | 2015-04-30 | 2016-11-03 | William Casey Fox | Bone intramedullary fixation scaffold |
US20180078293A1 (en) * | 2016-09-08 | 2018-03-22 | Meduloc, Llc | Implant and method for long bone fixation |
Non-Patent Citations (1)
Title |
---|
Machine English Translation of FR 2787313, espacenet.com, accessed April 26, 2023 * |
Also Published As
Publication number | Publication date |
---|---|
US20170319247A1 (en) | 2017-11-09 |
US20150073413A1 (en) | 2015-03-12 |
US10603088B2 (en) | 2020-03-31 |
US9724138B2 (en) | 2017-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200222090A1 (en) | Intermedullary devices for generating and applying compression within a body | |
EP3068325B1 (en) | Intermedullary devices for generating and applying compression within a body | |
US11602384B2 (en) | Methods for generating and applying compression within a body | |
EP3137645B1 (en) | Controlling the unloading stress of nitinol devices | |
JP6650395B2 (en) | Screw to generate and apply compression in the body | |
US9138274B1 (en) | Fasteners with shape changing bellows and methods using same | |
US12004787B2 (en) | Arthrodesis devices for generating and applying compression within joints | |
US8685024B2 (en) | Intramedullary fixation device and methods for bone fixation and stabilization | |
US20170252036A1 (en) | Devices for generating and applying compression within a body | |
US11350974B2 (en) | Bone intramedullary fixation scaffold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |